Skin cancers

Australian research adds third immune checkpoint inhibitor to the melanoma treatment toolkit

Australian researchers says they have obtained ‘breakthrough’ results showing a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients. Melanoma Institute Australia Co-Medical Director, Professor Georgina Long will be presenting results of the RELATIVITY-047 trial of relatlimab in melanoma at the American Society of Clinical Oncology virtual meeting this week. ...

Already a member?

Login to keep reading.

© 2021 the limbic